Article
A genetic study to identify pathogenic mechanisms and drug targets for benign prostatic hyperplasia: a multi-omics Mendelian randomization study.
Scientific reports - 4 Oct 2024
Liu Bohan, Wang Xinyi, Yang Zerui, Yin Zhaofa, Tang Cai, He Yushi, Ling Qi, Huang Zhongli, Feng Shijian
Abstract excerpt
Benign prostatic hyperplasia (BPH) as a common geriatric disease in urology, the incidence and prevalence are rapidly increasing with the aging society, prompting an urgent need for effective prevention and treatment of BPH. However, limited therapeutic efficacy and higher risk of complications result in the treatment of BPH remaining challenging. The unclear pathogenic mechanism also hampers further exploration...
Topics
Join the communities discussing this publication.